Crank, Elizabeth
Crank, Elizabeth was paid $901K by Medicaid between Nov 2019 and Dec 2024, across 11 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 39% of everything it billed.
33Billing provider infoCRANK, ELIZABETH
HAZARD, KY 41701
HAZARD, KY 41701
33aNPI1417153727assigned 06/23/2007
33bProvider typeRegistered Dietitian
28Total paid$901K
24GClaims30,587
24DCodes billed11
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers
Next to other Registered Dietitian providers in Kentucky
Rank by total paid#1 of 5
Median peer was paid$224K
This provider vs. median4.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 87 | $999.88 | |
| 2020 | 2,927 | $88K | |
| 2021 | 7,835 | $225K | |
| 2022 | 7,766 | $219K | |
| 2023 | 6,269 | $189K | |
| 2024incomplete | 5,703 | $178K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 39% | 13,426 | 11,431 | $355K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 9,822 | 8,397 | $220K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 15% | 969 | 905 | $131K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 14% | 1,575 | 1,449 | $123K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.0% | 1,141 | 1,001 | $36K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.9% | 2,137 | 1,856 | $36K |
| 36415 | Collection of venous blood by venipuncture | <1% | 120 | 88 | $25.76 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 426 | 304 | $0.39 |
| G9583 | Patients prescribed opiates for longer than six weeks | <1% | 418 | 301 | $0.22 |
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | <1% | 425 | 303 | $0.01 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 128 | 96 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.